Y10S514/81 - CPC Classification Index

ClassID:

242573 ⎘

Y10S514/81 - CPC Classification

Classification description:

Sub-classes:

Y10S514/811 » Alcohol 7
Y10S514/812 » Narcotic 28
Y10S514/813 » Tobacco 6

Recent Application in this class:

20180214443

2018-08-02

Pharmaceutical preparation containing oxycodone and naloxone

20170112828

2017-04-27

Pharmaceutical preparation containing oxycodone and naloxone

20150005335

2015-01-01

Matrix for sustained, invariant and independent release of active compounds

20140296277

2014-10-02

Pharmaceutical preparation containing oxycodone and naloxone

20140200236

2014-07-17

Opioid agonist/antagonist combinations

20140045878

2014-02-13

Matrix for sustained, invariant and independent release of active compounds

20120183612

2012-07-19

Matrix for sustained, invariant and independent release of active compounds

20120165359

2012-06-28

Opioid agonist/antagonist combinations

20120108621

2012-05-03

PHARMACEUTICAL PREPARATION CONTAINING OXYCODONE AND NALOXONE

#10

20100291203

2010-11-18

Opioid agonist/antagonist combinations

#11

20100092413

2010-04-15

Compositions and methods for alleviating skin disorders

#12

20090221714

2009-09-03

Pharmaceutical composition for prevention and treatment of drug or alcohol addiction or bipolar disorder using sodium phenylbutyrate

#13

20080292694

2008-11-27

Opioid agonist/antagonist combinations

#14

20080064724

2008-03-13

Composition Comprising Methylphenidate and Another Drug

#15

20070122348

2007-05-31

Opioid agonist/antagonist combinations

#16

20060078570

2006-04-13

Asafetida extract as medicine for abstinence of drugs

#17

20060014837

2006-01-19

Use of the (1S, 2R) enantiomer of milnacipran for the preparation of a drug

#18

20060014775

2006-01-19

Treatment of psychostimulant addiction

#19

20050287229

2005-12-29

Compositions for the treatment of neurological disorders

#20

20050245556

2005-11-03

Pharmaceutical preparation containing oxycodone and naloxone

#21

20050245483

2005-11-03

Matrix for sustained, invariant and independent release of active compounds

#22

20050192309

2005-09-01

Method of preventing abuse of opioid dosage forms